Long intergenic non-protein coding RNA 2583 (LINC02583)

LINC02583 (long intergenic non-protein coding RNA 2583) is classified as a long intergenic non-coding RNA (lincRNA), a subclass of long non-coding RNAs that are transcribed from genome regions not overlapping with protein-coding genes and are longer than 200 nucleotides[1][7]. LincRNAs—including LINC02583—participate in gene expression regulation through mechanisms such as chromatin remodeling, influencing three-dimensional genome architecture, modulating the stability of RNAs, and acting as enhancers or repressors in transcription[1][5]. These regulatory functions may be tissue-specific but most lincRNAs, including LINC02583, remain largely uncharacterized with respect to their detailed molecular mechanisms and disease involvements[1][7]. There is currently no evidence that LINC02583 serves as a direct therapeutic target (such as a receptor, enzyme, transporter, or transcription factor), and there are no known drugs, mechanisms of action, or established biomarker roles associated with this lincRNA[7]. While lincRNAs are increasingly recognized as important regulators that may be implicated in disease (for example, various cancers and other regulatory disorders[1][5][3]), no disease association or direct functional studies for LINC02583 are available in the current biomedical literature.

Other names

LINC02583

Not applicable; no drugs targeting LINC02583 found